Research study Program year 2022 Source: CMS Open Payments

18-Avp-786-207

Research payments

$2,124,537

463 payments

Through program year 2022, $2,124,537 in research payments was reported against 18-Avp-786-207, across 463 payments, paid by Avanir Pharmaceuticals, Inc..

Paid by: Avanir Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$180,024	126
2021	Research	$732,037	168
2020	Research	$1,052,157	130
2019	Research	$160,319	39

Breakdown

Who paid Research payments · program years 2019–2022

Avanir Pharmaceuticals, Inc. $2,124,537 463 payments

Who received the money Research payments · program years 2019–2022

Hassman Research Institute, LLC Organisation paid for research $194,593 33 payments
Pillar Clinical Research, Llc Organisation paid for research $126,219 17 payments
Srsd INC Dba Synergy East Organisation paid for research $118,196 21 payments
Citrials INC Organisation paid for research $117,749 17 payments
Synexus Organisation paid for research $116,144 23 payments
Arch Clinical Trials, LLC Organisation paid for research $114,237 18 payments
Collaborative Neuroscience Network, LLC Organisation paid for research $81,506 28 payments
Keystone Clinical Studies Organisation paid for research $80,466 7 payments
Advanced Research Center, INC Organisation paid for research $72,139 15 payments
Premier Clinical Research Organisation paid for research $65,885 11 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.